Search
Vociprotafib
go.drugbank.com/drugs/DB21559InvestigationalVociprotafib is under investigation in clinical trial NCT05054725 (Combination Study of RMC-4630 and Sotorasib for NSCLC Subjects With KRASG12C Mutation After Failure of Prior Standard Therapies).
TGAAC94
go.drugbank.com/drugs/DB06175InvestigationaltgAAC94 is a recombinant adeno-associated virus serotype 2 (AAV2) vector containing the cDNA for a human tumor necrosis factor receptor (TNFR)-immunoglobulin (IgG1) Fc fusion (TNFR:Fc) gene.
Ioxilan
go.drugbank.com/drugs/DB09135ApprovedWithdrawnIoxilan is a tri-iodinated diagnostic contrast agent. Intravascular injection results in opacification of vessels in the path of flow of the contrast medium, permitting radiographic visualization of the internal structures of the human b...
Categories: Compounds used in a research, industrial, or household settingIothalamic acid
go.drugbank.com/drugs/DB09133ApprovedIothalamic acid is an iodine containing organic anion used as a diagnostic contrast agent.
Categories: Compounds used in a research, industrial, or household settingTJ003234
go.drugbank.com/drugs/DB16470InvestigationalCategories: Experimental Unapproved Treatments for COVID-19LV-SMENP Vaccine
go.drugbank.com/drugs/DB15804ExperimentalAs of August 2020, this vaccine is being tested for prophylaxis against COVID-19 in human clinical trials.
Atirmociclib
go.drugbank.com/drugs/DB21733InvestigationalAtirmociclib is under investigation in clinical trial NCT06760637 (Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for
Picolinic acid
go.drugbank.com/drugs/DB05483ExperimentalPCL-016 or Picolinic acid drug substance is a pyridine carboxylate metabolite of tryptophan.
Categories: Compounds used in a research, industrial, or household settingAluminium acetoacetate
go.drugbank.com/drugs/DB13280ExperimentalAluminium acetoacetate is an aluminum containing antacid.
Categories: Drugs for Acid Related DisordersOSI-930
go.drugbank.com/drugs/DB05913InvestigationalOSI-930 is an orally active inhibitor of two clinically validated targets: c-Kit and the vascular endothelial growth factor receptor-2 (VEGFR-2). OSI-930 is designed to target both cancer cell proliferation and blood vessel growth (angio...